share_log

桂林三金(002275.SZ)发布上半年业绩,净利润3.01亿元,下降20.70%

Guilin Sanjin Pharmaceutical (002275.SZ) announced its performance for the first half of the year, with a net income of 0.301 billion yuan, a decrease of 20.70%.

Zhitong Finance ·  Aug 28 18:13

Guilin Sanjin (002275.SZ) released the semi-annual report for 2024, during which the company achieved revenue...

According to the semi-annual report for 2024 released by Guilin Sanjin (002275.SZ), the company achieved revenue of 1.068 billion yuan during the reporting period, a decrease of 10.53% compared to the same period last year. The net income attributable to shareholders of the listed company was 0.301 billion yuan, a decrease of 20.70% compared to the same period last year. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.274 billion yuan, a decrease of 25.21% compared to the same period last year. The basic earnings per share was 0.51 yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment